93 related articles for article (PubMed ID: 14558439)
1. Prevention of islet allograft rejection in diabetic mice by targeting Janus Kinase 3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (JANEX-1).
Cetkovic-Cvrlje M; Dragt AL; Uckun FM
Arzneimittelforschung; 2003; 53(9):648-54. PubMed ID: 14558439
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.
Cetkovic-Cvrlje M; Uckun FM
Br J Haematol; 2004 Sep; 126(6):821-7. PubMed ID: 15352986
[TBL] [Abstract][Full Text] [Related]
3. Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice.
Cetkovic-Cvrlje M; Roers BA; Waurzyniak B; Liu XP; Uckun FM
Blood; 2001 Sep; 98(5):1607-13. PubMed ID: 11520814
[TBL] [Abstract][Full Text] [Related]
4. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
5. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97).
Malaviya R; Chen CL; Navara C; Malaviya R; Liu XP; Keenan M; Waurzyniak B; Uckun FM
J Pharmacol Exp Ther; 2000 Dec; 295(3):912-26. PubMed ID: 11082424
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model.
Uckun FM; Roers BA; Waurzyniak B; Liu XP; Cetkovic-Cvrlje M
Blood; 2002 Jun; 99(11):4192-9. PubMed ID: 12010825
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
[TBL] [Abstract][Full Text] [Related]
8. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
du Toit D; Muller C; Page B; Louw J
Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976
[TBL] [Abstract][Full Text] [Related]
9. Treatment of post-bone marrow transplant acute graft-versus-host disease with a rationally designed JAK3 inhibitor.
Cetkovic-Cvrlje M; Roers BA; Schonhoff D; Waurzyniak B; Liu XP; Uckun FM
Leuk Lymphoma; 2002 Jul; 43(7):1447-53. PubMed ID: 12389628
[TBL] [Abstract][Full Text] [Related]
10. Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
Uckun FM; Erbeck D; Qazi S; Venkatachalam T; Tibbles HE; Vassilev A
Arzneimittelforschung; 2007; 57(6):320-9. PubMed ID: 17688077
[TBL] [Abstract][Full Text] [Related]
11. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
12. CYP1A-mediated metabolism of the Janus kinase-3 inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline: structural basis for inactivation by regioselective O-demethylation.
Uckun FM; Thoen J; Chen H; Sudbeck E; Mao C; Malaviya R; Liu XP; Chen CL
Drug Metab Dispos; 2002 Jan; 30(1):74-85. PubMed ID: 11744615
[TBL] [Abstract][Full Text] [Related]
13. Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.
Cetkovic-Cvrlje M; Dragt AL; Vassilev A; Liu XP; Uckun FM
Clin Immunol; 2003 Mar; 106(3):213-25. PubMed ID: 12706408
[TBL] [Abstract][Full Text] [Related]
14. Prevention of UVB-induced skin inflammation, genotoxicity, and photocarcinogenesis in mice by WHI-P131, a dual-function inhibitor of Janus kinase 3 and EGF receptor kinase.
Uckun FM; Dibirdik I; Qazi S
Arzneimittelforschung; 2010; 60(4):218-25. PubMed ID: 20486473
[TBL] [Abstract][Full Text] [Related]
15. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
[No Abstract] [Full Text] [Related]
16. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
17. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection.
Aharoni R; Yussim A; Sela M; Arnon R
Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456
[TBL] [Abstract][Full Text] [Related]
20. Permanent acceptance of mitomycin C-treated islet allograft.
Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
